Compare IKT & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IKT | INSE |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 179.5M |
| IPO Year | 2020 | 2014 |
| Metric | IKT | INSE |
|---|---|---|
| Price | $2.23 | $6.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $5.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.1M | 144.4K |
| Earning Date | 03-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $199,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.25 |
| 52 Week Low | $1.33 | $6.11 |
| 52 Week High | $2.36 | $9.95 |
| Indicator | IKT | INSE |
|---|---|---|
| Relative Strength Index (RSI) | 71.21 | 34.15 |
| Support Level | $1.63 | $6.29 |
| Resistance Level | $2.36 | $8.42 |
| Average True Range (ATR) | 0.16 | 0.41 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 72.22 | 9.79 |
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.
Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.